top of page
Home: Who We Are

HEAD & NECK CANCER INTERNATIONAL GROUP

Welcome.

The Head and Neck Cancer International Group aims to promote and conduct high quality clinical trials in order to improve outcomes in patients with head and neck cancers. We achieve this through international collaboration, a strong sense of common purpose, shared expertise, and mutual respect among members.

The HNCIG consensus minimum database and its accompanying data dictionary is available for use for research purposes. While HNCIG provides this resource at no cost to academic investigators, industry-sponsored studies will be subject to a licensing fee. For details regarding access and fees, please contact secretariat@hncig.org.

Research Proposals

Research Proposals are invited via the application portal.

​

The online application form may be accessed here.

Applications will be initially assessed by the New Project Review Group, which meets monthly. If deemed suitable, the application will then be forwarded to the appropriate Sub-committee (e.g. Clinical Studies, Translational Studies, Young Investigator, Guidelines & Protocols) who have established protocols which will enable a more thorough examination of the proposal.

The applicant will be kept informed of the progress of the application.

PORTUGAL FLYER.PNG
Home: List

AIMS OF HNCIG

Promote international collaboration
Promote clinical research
Perform studies in rare tumors
Harmonize the technical aspects of radiation delivery
Develop a credentialing process for novel radiation and surgical approaches
Promote translational research
Stimulate evidence-based medicine
Support educational activities
Multinational, real-world data and AI studies
Harmonization of head and neck cancer research  protocols, methodologies, and endpoints

Would you like to be more involved with HNCIG?

Positions currently available:

  • Co-Chair and Deputy Chair of the Scientific Translational Studies Committee

  • Members of a task-and-finish working group for establishing an international clinical trials platform

The Scientific Translational Subcommittee of the Head and Neck Cancer International Group (HNCIG) is looking for a new Co-Chair and a Deputy Chair. The HNCIG is a fantastic network for conducting translational research. The lead is required to actively develop projects and to co-ordinate members' projects. This includes organising regular meetings of the committee members. In addition, an intensive exchange with the other subcommittees of the HNCIG is necessary in order to harmonise the activities of the entire society.  It is necessary to regularly submit a report on the committee's activities to the HNCIG Board. The Terms of Reference of the Committee is available here

Please contact the HNCIG secretariat or the current Co-Chair for further information Jens Peter Klussmann:  jens.klussmann@uk-koeln.de

​

HNCIG International Trials Platform Working Group

HNCIG is establishing an International Clinical Trials Platform to facilitate collaboration between its Member Groups, and the running of multinational academic and industry trials in head neck cancer.

This task-and-finish ITP Working Group (ITP WG) will be part of the Clinical Trials Scientific Committee chaired by Dr. Ana Gomes and Dr. Melvin Chua. The ITP Working Group will be jointly chaired by Drs. Melvin Chua and Hisham Mehanna.

HNCIG is inviting interested individuals including clinicians, academics and clinical trial staff to apply for membership of the ITP WG. Experience in international clinical trials (whether academic or industry) is desirable, as is experience in trial delivery, regulation, monitoring and design. Early career researchers are also encouraged to apply, even if they do not have experience in trials, provided they are willing to be actively involved.

Please click here for further information.

Closing date for applications, 21st May 2025.

Dazzling Light

SCIENTIFIC COMMITTEE

Open Laptop

GUIDELINES & PROTOCOLS COMMITTEE

People Walking

YOUNG INVESTIGATOR COMMITTEE

Two Men Shaking Hands

PARTNERSHIPS COMMITTEE

Elegant Abstract Background

DATABASE COMMITTEE

2021-06-28 09_30_07-Head & Neck logo High Res (1).pdf.png

Our logo was designed by Steve Smith, graphic designer from Leicestershire, England. Since studying graphic design at York University, he has spent the last 30 years running his own small company. He was inspired to design our logo after reading about our research and efforts. Thank you, Steve.

Merck has supported HNCIG with unrestricted grants for medical education and treatment guidelines.
Subscribe to the HNCIG Newsletter

Thanks for subscribing!

Head & Neck Cancer International Group

©2023 by Head & Neck Cancer International Group.

bottom of page